BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li L, Han DK, Lu J. Interferon-α induced severe thrombocytopenia: A case report and review of the literature. World J Gastroenterol 2010; 16(11): 1414-1417 [PMID: 20238410 DOI: 10.3748/wjg.v16.i11.1414]
URL: https://www.wjgnet.com/1007-9327/full/v16/i11/1414.htm
Number Citing Articles
1
Weimin Jiang, Hisashi Hidaka, Takahide Nakazawa, Hiroyuki Kitagawa, Wasaburo Koizumi. Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)–CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case reportBMC Research Notes 2014; 7(1) doi: 10.1186/1756-0500-7-141
2
Current awareness: Pharmacoepidemiology and drug safetyPharmacoepidemiology and Drug Safety 2010; 19(10) doi: 10.1002/pds.1855
3
Richard H. Aster. Platelets2019; : 725 doi: 10.1016/B978-0-12-813456-6.00040-0
4
Jonathan E. Schelfhout, Danijela A. Stojanovic, Amy Houtchens, Heidi M. Crane, Edward R. Cachay, Elizabeth R. Brown, Sonia M. Napravnik, Mari M. Kitahata, Michael S. Saag, Peter W. Hunt, Teresa L. Kauf, Joseph A. C. Delaney. Progression of Platelet Counts in Treatment Naïve HIV/HCV Co-InfectionWorld Journal of AIDS 2013; 3(01): 36 doi: 10.4236/wja.2013.31006
5
Rosario Arena, Paolo Cecinato, Andrea Lisotti, Federica Buonfiglioli, Claudio Calvanese, Giuseppe Grande, Marco Montagnani, Francesco Azzaroli, Giuseppe Mazzella. Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literatureWorld Journal of Hepatology 2015; 7(12): 1718-1722 doi: 10.4254/wjh.v7.i12.1718
6
Beng H. Chong, James J. -H. Chong. Platelets in Thrombotic and Non-Thrombotic Disorders2017; : 771 doi: 10.1007/978-3-319-47462-5_52
7
Mariana Brandi Mendonça Pinheiro, Stephane Vicente Rozini, Anna Cecíllia Quirino-Teixeira, Giselle Barbosa-Lima, Juliana F. Lopes, Carolina Q. Sacramento, Fernando A. Bozza, Patrícia T. Bozza, Eugenio D. Hottz. Dengue induces iNOS expression and nitric oxide synthesis in platelets through IL-1RFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1029213
8
Tomohisa Saito, Satofumi Iida, Takehiko Kawanishi. Population Pharmacokinetic-Pharmacodynamic Modeling and Simulation of Platelet Decrease Induced by Peg-interferon-alpha 2aDrug Metabolism and Pharmacokinetics 2012; 27(6): 614 doi: 10.2133/dmpk.DMPK-11-RG-148
9
Mahtabalsadat Mirjalili, Mojtaba Shafiekhani, Afsaneh Vazin. <p>Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen</p>Therapeutics and Clinical Risk Management 2020; : 617 doi: 10.2147/TCRM.S256246
10
Richard H. Aster. Platelets2013; : 835 doi: 10.1016/B978-0-12-387837-3.00041-9
11
Yuichi Honma, Michihiko Shibata, Tsuguru Hayashi, Masashi Kusanaga, Noriyoshi Ogino, Sota Minami, Shinsuke Kumei, Shinji Oe, Koichiro Miyagawa, Michio Senju, Hidehiko Matsuoka, Tatsuyuki Watanabe, Masaaki Hiura, Shintaro Abe, Masaru Harada. Effect of direct‐acting antivirals on platelet‐associated immunoglobulin G and thrombocytopenia in hepatitis C virus‐related chronic liver diseaseLiver International 2019; 39(9): 1641 doi: 10.1111/liv.14120
12
Nancy E. Everds, Jacqueline M. Tarrant. Unexpected Hematologic Effects of Biotherapeutics in Nonclinical Species and in HumansToxicologic Pathology 2013; 41(2): 280 doi: 10.1177/0192623312467400